...
首页> 外文期刊>International Journal of Pharmaceutical Sciences Review and Research >Formulation and Evaluation of Cefpodoxime Proxetil Dispersible Tablet
【24h】

Formulation and Evaluation of Cefpodoxime Proxetil Dispersible Tablet

机译:头孢泊肟普罗西汀分散片的研制与评价

获取原文
           

摘要

Solubility of a drug is a major concern for its therapeutic action and becomes more prominent when the drug is lipophilic in nature. Zaltoprofen is a novel non–steroidal anti-inflammatory class of drug, but problem associated with is the poor solubility in biological fluids. The present study was performed to investigate the effect of different stabilizers (in single or in combination form) on solubility, particle size, zeta potential, dissolution rate and stability of nano suspension of water insoluble drug Zaltoprofen. Nanosuspension is prepared by using wet mill, high pressure homogenizer, precipitation, and melt emulsification method. In the present work nano suspension was prepared by solvent/anti solvent precipitation method using different steric stabilizers like pluronic F-68, F-127and electrostatic stabilizer like sodium lauryl sulphate. The optimized formulation showed an average particle size 179nm and a zeta potential of -28.4mV. The rate of dissolution of the optimized nano suspension was enhanced (82% in 45min), relative to bulk drug of Zaltoprofen (22% in 45min), mainly due to the formation of nanosized particles. The obtained results showed that nano suspension prepared in combination form of stabilizers like pluronic F-68 and sodium lauryl sulphate has improved dissolution rate. The increase in in-vitro dissolution rate may favourably affect bioavailability and improve safety for the patient by decreasing gastric irritancy. Stability study revealed that nano suspension was more stable at room and refrigerator condition with no significant change in particle size distribution. The results indicate that the combination of stabilizers may contribute in enhancement of the solubility, dissolution rate, and stability.
机译:药物的溶解度是其治疗作用的主要关注点,并且当药物本质上是亲脂性时变得更加突出。 Zaltoprofen是一种新型的非甾体类抗炎药,但与之相关的问题是其在生物液体中的溶解性差。进行本研究以研究不同稳定剂(单一或组合形式)对水不溶性药物扎托洛芬纳米悬浮液的溶解度,粒度,ζ电位,溶出速率和稳定性的影响。纳米悬浮液是通过使用湿磨机,高压均质器,沉淀和熔融乳化法制备的。在本工作中,使用不同的空间稳定剂(如普朗尼克F-68,F-127)和静电稳定剂(如十二烷基硫酸钠)通过溶剂/抗溶剂沉淀法制备纳米悬浮液。优化的配方显示平均粒径为179nm,ζ电位为-28.4mV。相对于Zaltoprofen的散装药物(45分钟内为22%),优化后的纳米悬浮液的溶出速率得到了提高(45分钟内为82%),这主要是由于形成了纳米颗粒。所得结果表明,以稳定剂如普鲁尼克F-68和十二烷基硫酸钠的组合形式制备的纳米悬浮液具有改善的溶解速率。体外溶出速率的增加可能会通过降低胃部刺激性而有利地影响生物利用度并提高患者的安全性。稳定性研究表明,纳米悬浮液在室温和冰箱条件下更稳定,粒径分布没有明显变化。结果表明,稳定剂的组合可能有助于提高溶解度,溶解速率和稳定性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号